These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 10306915)

  • 1. Analysis of drug reports for the P&T Committee.
    Longe RL; Cross GW; Riley MW
    Hosp Formul; 1978 Mar; 13(3):228-9. PubMed ID: 10306915
    [No Abstract]   [Full Text] [Related]  

  • 2. A systematic approach to writing P&T drug reports.
    Longe RL
    Hosp Formul; 1978 Feb; 13(2):128-9. PubMed ID: 10306341
    [No Abstract]   [Full Text] [Related]  

  • 3. Developing Drug Reports for the Pharmacy and Therapeutics Committee.
    Longe RL; Riley MW
    Am J Hosp Pharm; 1976 Jul; 33(7):651-2. PubMed ID: 941920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of pharmacy and therapeutics committee drug evaluation reports.
    Majercik PL; May JR; Longe RL; Johnson MH
    Am J Hosp Pharm; 1985 May; 42(5):1073-6. PubMed ID: 4003418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Role of drug information].
    Lunde PK
    Tidsskr Nor Laegeforen; 1977 Jan; 97(3):150-1. PubMed ID: 835120
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmacy newsletters: time for a new approach.
    Mitchell JF
    Hosp Formul; 1985 Mar; 20(3):360, 363-5. PubMed ID: 10270308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Reply 1: LAKSAK supports wise drug therapy using knowledge and sharp IT-tools].
    Gustafsson LL; Hensjö LO
    Lakartidningen; 2000 Sep; 97(39):4347. PubMed ID: 11076480
    [No Abstract]   [Full Text] [Related]  

  • 8. [Drug committees, choice of drugs and drug information].
    Lundh B
    Lakartidningen; 1988 Nov; 85(44):3641-3. PubMed ID: 3199994
    [No Abstract]   [Full Text] [Related]  

  • 9. [Drug committees are not necessary--therapeutic recommendations are issued anyway].
    Jönsson B
    Lakartidningen; 2005 Jul 11-24; 102(28-29):2085-6: discussion 290-2. PubMed ID: 16097181
    [No Abstract]   [Full Text] [Related]  

  • 10. [Future drug committees--institutions for cooperation and information].
    Odeberg H; Lenhoff K
    Lakartidningen; 1989 Jan; 86(1-2):34. PubMed ID: 2911227
    [No Abstract]   [Full Text] [Related]  

  • 11. The role of the microbiology laboratory in guiding formulary decisions.
    Stratton CW
    Hosp Formul; 1988 Aug; 23(8):654-7. PubMed ID: 10312591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Drug committees' information leaflets are needed].
    Asberg KH
    Lakartidningen; 2009 Sep 16-22; 106(38):2384. PubMed ID: 19848349
    [No Abstract]   [Full Text] [Related]  

  • 13. [Letter: The role of the National Board of Health and Welfare in drug information].
    Liljestrand A; Rosén A
    Lakartidningen; 1976; 73(20):1881-2. PubMed ID: 1271917
    [No Abstract]   [Full Text] [Related]  

  • 14. How expert opinion influences P&T decisions.
    Manag Care; 2010 May; 19(5):52. PubMed ID: 20524369
    [No Abstract]   [Full Text] [Related]  

  • 15. Medi-messages.
    Jeffrey LP
    Hosp Formul; 1982 Dec; 17(12):1664-5. PubMed ID: 10258760
    [No Abstract]   [Full Text] [Related]  

  • 16. Drug information services in Nepal: the changing perspectives.
    Chhetri AK; Palaian S; Mishra P
    Kathmandu Univ Med J (KUMJ); 2008; 6(1):117-21. PubMed ID: 18604128
    [No Abstract]   [Full Text] [Related]  

  • 17. [Local drug information--who is responsible?].
    Henningsson S
    Lakartidningen; 1994 Apr; 91(15):1485-6. PubMed ID: 8183031
    [No Abstract]   [Full Text] [Related]  

  • 18. [Proposal for agreement and budget for a Scandinavian pharmacy and therapeutics committee].
    Idänpään-Heikkilä J
    Nord Med; 1974 Jan; 89(1):12. PubMed ID: 4819424
    [No Abstract]   [Full Text] [Related]  

  • 19. The DERP: is it an effective methodology?
    Heaton AH
    Health Aff (Millwood); 2006; 25(4):W276-8. PubMed ID: 16757488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strategic planning for biotechnology products.
    Wordell CJ
    Hosp Pharm; 1992 Jun; 27(6):521-4, 528. PubMed ID: 10118596
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.